Document is current
Any future updates will be listed below
-
Authors
Spradlin, Jessica N.
Hu, Xirui
Ward, Carl C.
Brittain, Scott M.
Jones, Michael D.
Ou, Lisha
To, Milton
Proudfoot, Andrew
Ornelas, Elizabeth
Woldegiorgis, Mikias
Olzmann, James A. https://orcid.org/0000-0001-7751-8316
Bussiere, Dirksen E.
Thomas, Jason R.
Tallarico, John A.
McKenna, Jeffrey M.
Schirle, Markus
Maimone, Thomas J. https://orcid.org/0000-0001-5823-692X
Nomura, Daniel K. https://orcid.org/0000-0003-1614-8360
- License Information
-
More Information
Article History
Received: 15 October 2018
Accepted: 8 May 2019
First Online: 17 June 2019
Competing interests
: S.M.B., M.D.J., A.P., E.O., M.W., D.E.B., J.A.T., J.M.K. and M.S. are employees of Novartis Institutes for BioMedical Research. J.R.T. was an employee of Novartis Institutes for BioMedical Research when this study was submitted, but is now an employee of Vertex Pharmaceuticals. This study was funded by the Novartis Institutes for BioMedical Research and the Novartis-Berkeley Center for Proteomics and Chemistry Technologies. D.K.N. is a co-founder, share-holder and adviser for Artris Therapeutics and Frontier Medicines.
